HRMY - Harmony Biosciences Holdings - Stock Forecast

Healthcare - Sector
Coverage Performance Price Targets & Ratings Chart Insider Trading

HRMY is currently covered by 9 analysts with an average price target of $41.1. This is a potential upside of $11.32 (38.01%) from yesterday's end of day stock price of $29.78.

Harmony Biosciences Holdings's activity chart (see below) currently has 12 price targets and 62 ratings on display. The stock rating distribution of HRMY is 82.35% BUY, 9.8% HOLD and 7.84% SELL.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 44.91% with an average time for these price targets to be met of 100.22 days.

Highest price target for HRMY is $69, Lowest price target is $27, average price target is $41.1.

Most recent stock forecast was given by CHARLES DUNCAN from CANTOR FITZGERALD on 28-Mar-2024. First documented stock forecast 11-Sep-2020.

Split History since 2000:

12/5/00 3 for 1

Currently out of the existing stock ratings of HRMY, 42 are a BUY (82.35%), 5 are a HOLD (9.8%), 4 are a SELL (7.84%).

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

49

$19.16 (64.21%)

49

20 days ago

0/5 (0%)

$15.42 (45.92%)

Buy

40

$10.16 (34.05%)

42

1 months 21 days ago

8/18 (44.44%)

$6.52 (19.47%)

106

Buy

50

$20.16 (67.56%)

53

1 months 25 days ago

3/13 (23.08%)

$17.5 (53.85%)

332

Sell

28

$-1.84 (-6.17%)

25

3 months 8 days ago

5/6 (83.33%)

$-4.59 (-14.08%)

14

Buy

27

$-2.84 (-9.52%)

26

5 months 16 days ago

4/6 (66.67%)

$2.48 (10.11%)

133

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is HRMY (Harmony Biosciences Holdings) average time for price targets to be met?

On average it took 100.22 days on average for the stock forecasts to be realized with a an average price target met ratio 44.91

Which analyst has the current highest performing score on HRMY (Harmony Biosciences Holdings) with a proven track record?

AMI FADIA

Which analyst has the current lower performing score on HRMY (Harmony Biosciences Holdings) with a proven track record?

CHARLES DUNCAN

Which analyst has the most public recommendations on HRMY (Harmony Biosciences Holdings)?

Ami Fadia works at NEEDHAM and has 7 price targets and 8 ratings on HRMY

Which analyst is the currently most bullish on HRMY (Harmony Biosciences Holdings)?

Francois Brisebois with highest potential upside - $39.16

Which analyst is the currently most reserved on HRMY (Harmony Biosciences Holdings)?

Danielle Brill with lowest potential downside - -$2.84

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?